Expert Interview
Discussing Regeneron's Eylea (aflibercept) HD uptake and trends following the April 1 J-Code
Ticker(s): REGN, RHHBYInstitution: Bascom Palmer Eye Institute
- Chair in Ophthalmology, Professor of Ophthalmology, and attending ophthalmologist at Bascom Palmer Eye Institute
- Treats a high volume of patients with WET AMD
- Internationally recognized and respected vitreoretinal specialist; presented lectures in more than a dozen foreign countries, Fellow of American Academy of Ophthalmology, and member of American Society of Retinal Specialists
Roughly how many patients do you manage with wet amd?
Added By: c_adminHow many are on Eylea?
Added By: c_adminHow will the J code impact your prescribing patterns?
Added By: c_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
